Huddinge

• PHASE II STUDY OF AZACITIDINE IN COMBINATION WITH LOW DOSE INTENSITY VENETOCLAX IN PATIENTS WITH ACUTE MYELOID LEUKEMIA WITH INTEGRATION OF … Recruiting
  2023-510415-19-00 4 2024-08-28 Acute Myeloid Leukemia
• A Phase 3 Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN) Recruiting
  2022-502629-16-00 5 2024-07-10 Hemolytic Disease of the Fetus and Newborn (HDFN)
• FAPI-PET imaging in solid tumors Recruiting
  2024-514967-25-00 4 2024-07-03 Cancer
• Effects by botulinum toxin in patients with jaw muscle pain Recruiting
  2024-514739-12-00 4 2024-06-20 Myogenous temporomandibular disorders (TMDM)
• COMeBAC- COMparison between Bensypenicillin And Cloxacillin treatment in PSSA Recruiting
  2023-506860-15-00 6 2024-06-11 Staphylococcus aureus bacteraemia
• C1071032 - MAGNETISMM-32 A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMAL … Recruiting
  2023-507871-23-00 5 2024-05-27 Relapsed/Refractory Multiple Myeloma
• Basket study for oligo-metastatic breast cancer - ANISE Recruiting
  2023-505039-11-00 4 2024-05-02 breast cancer, HER2-positive, oligometastatic disease
• A Phase I/IIa multicenter study evaluating the safety and efficacy of CAR20(NAP)-T in patients with relapsed/refractory B cell lymphoma (CAR … Recruiting
  2024-511844-18-00 7 2024-05-02 Relapsed or refractory CD20+ diffuse large B-cell lymphoma, mantle cel
• Study to learn about the safety of fazirsiran and if it can help people with alpha-1 antitrypsin liver disease with mild liver scarring (fib … Recruiting
  2023-504198-19-00 5 2024-04-18 Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
• Bomedemstat vs Best Available Therapy (BAT) for Essential Thrombocythemia Recruiting
  2023-504865-21-00 5 2024-04-15 Essential Thrombocythemia patients who have an inadequate response to
• RECOVERY Recruiting
  2023-507441-29-00 5 2024-02-29 Pneumonia
• Open label randomized, multicentre, controlled trial of pancreatic enzyme replacement therapy (PERT) for pancreatic exocrine insufficiency ( … Recruiting
  2023-507367-18-00 6 2024-02-14 Pancreatic exocrine insufficiency
• Preeclampsia Intervention 4 Recruiting
  2022-502707-29-00 5 2024-02-07 Preeclampsia
• Mifepristone and Letrozole in Ectopic Pregnancy (MILE) Recruiting
  2023-503935-16-00 4 2023-12-15 Ectopic pregnancy
• A study to investigate the safety and clinical activity of belantamab for the treatment of multiple myeloma when used as monotherapy and in … Recruiting
  2022-501941-63-00 7 2023-12-13 Multiple myeloma
• Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting
  2023-503582-35-00 6 2023-10-26 Staphylococcus aureus bacteremia
• Short or long NAT for BR/LAPC (ADVANTAGE) Recruiting
  2022-502117-29-00 5 2023-10-19 Advanced pancreatic cancer
• PARP-PET in solid tumors Recruiting
  2022-502918-87-00 3 2023-10-02 cancer patients
• Evaluation of Long-Term Safety and Efficacy of Vanzacaftor/Tezacaftor/Deutivacaftor in Cystic Fibrosis Subjects 1 Year of Age and Older Recruiting
  2022-503081-74-00 5 2023-09-05 Cystic Fibrosis
• A Study to Evaluate the Efficacy and Safety of XyloCore, a Glucose Sparing Experimental Solution, for Peritoneal Dialysis (ELIXIR) Recruiting
  2024-513562-19-00 5 2023-08-30 End-Stage Kidney Disease
• Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnorma … Recruiting
  2022-501943-34-00 5 2023-06-27 Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
• Observational Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Patients with Chronic hepatitis D Recruiting
  2023-504414-29-00 11 2023-06-19 hepatitis D
• Desensitisation with imlifidase prior to kidney transplant in highly sensitised children Recruiting
  2022-500230-28-00 4 2023-06-02 Highly sensitised paediatric patients with a positive crossmatch again
• Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis Subjects 1 Through 11 Years of Age Recruiting
  2024-513754-29-00 5 2023-03-06 Cystic Fibrosis

Showing 73–96 of 215 trials